Tirzepatide for PCOS (2026) Updated · 0d ago
Quick answer: Tirzepatide (Mounjaro/Zepbound) is FDA-approved for obesity, not PCOS specifically. Off-label use in PCOS gaining traction — addresses insulin resistance and weight, both central to PCOS metabolic phenotype.
Tirzepatide in PCOS care
Evidence summary, dosing guidance, and outcomes data for Tirzepatide in the management of PCOS.